IFM Bids $4.9B for Atlas Arteria, Citing Poor Performance

IFM Investors Proposes A$6.89 Billion Takeover

IFM Investors has submitted a cash offer of A$6.89 billion, equivalent to $4.92 billion, to acquire the Australian toll road operator Atlas Arteria. The proposal cites the firm's consistent underperformance in delivering shareholder value.

Offer Details and Rationale

The offer stands at A$4.75 per share, a 9.7% premium over Atlas Arteria's last closing price. IFM, which already holds a 34.8% stake, stated it would increase the offer to A$5.10 per share if its interest reaches 45%. The fund highlighted Atlas Arteria's poor shareholder returns over the past five years and lagging operational performance as key reasons for the bid.

Market Impact and Context

The takeover bid follows a period of weak performance for Atlas Arteria shares, which have declined significantly this year against a mildly positive ASX 200 index. IFM also expressed concerns about risks associated with Atlas Arteria's potential pursuit of further merger opportunities following its 2022 acquisition of a stake in the Chicago Skyway.

Outlook for Atlas Arteria

This unsolicited offer places pressure on the Atlas Arteria board to respond. Shareholders will be closely watching for the board's official recommendation and any potential counter-offers, as the bid's success hinges on securing further shareholder support.

FAQ

Q: What is the total value of IFM Investors' offer?
A: The cash offer is for A$6.89 billion, or approximately $4.92 billion.

Q: Why is IFM Investors making this bid?
A: IFM cites Atlas Arteria's underperformance in shareholder returns and operational areas over the last five years.

Source: Investing.com